Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Koen B. Pouwels(University of Oxford), Andrew Walker(University of Oxford), Nicole Stoesser(John Radcliffe Hospital), Karina-Doris Vihta(National Institute for Health and Care Research), Emma Rourke(Office for National Statistics), Thomas House(University of Manchester), Ruth Studley(Office for National Statistics), Philippa C. Matthews(University College London Hospitals NHS Foundation Trust), Duncan Cook(Office for National Statistics), Emma Pritchard(National Institute for Health and Care Research), John Newton(University of Exeter), David W. Eyre(Health Protection Scotland), Ian Diamond(Office for National Statistics), Jeremy Farrar(World Health Organization), Derrick W. Crook(John Radcliffe Hospital), Jodie Hay(University of Glasgow), John I. Bell(University of Oxford), Tim Peto(John Radcliffe Hospital)
Nature Medicine
October 14, 2021
Cited by 564


Related Papers

Dengue: a continuing global threat
|Nature Reviews Microbiology|2010|2.1k
Into the Eye of the Cytokine Storm
|Microbiology and Molecular Biology Reviews|2012|2k
Dengue
|New England Journal of Medicine|2012|1.7k